(marketscreener.com) Quantum Genomics gives an update Quantum Genomics , a biopharmaceutical company specialising in the development of a new class of medications that directly target the brain gives an update following the negative FRESH study results' announcement of last October 28, 2022. Cash position Cash position of the Company was M€ 10.6 as...https://www.marketscreener.com/quote/stock/QUANTUM-GENOMICS-16253203/news/Quantum-Genomics-Quantum-Genomics-gives-an-update-42507694/?utm_medium=RSS&utm_content=20221208
Quantum Genomics is a France-based biopharmaceutical company that develops and commercializes APA inhibitor drugs for the treatment of arterial hypertension and heart failure.